Literature DB >> 12774220

Cardiovascular calcifications in pediatric patients receiving maintenance dialysis.

Rita D Sheth1, Maria D Perez, Stuart L Goldstein.   

Abstract

Cardiovascular disease is a major cause of morbidity and mortality in adult patients with end-stage renal disease receiving maintenance dialysis. Coronary artery calcifications (CAC) contribute to the high prevalence of cardiac disease and are associated with hyperphosphatemia, an elevated calcium-phosphorus product (CaxP), and prolonged time on dialysis. Chronic inflammation and malnutrition are also associated with an increased risk for development of cardiac calcifications. Young adults receiving maintenance dialysis develop cardiac calcifications at a degree out of proportion to healthy adults of the same age and gender. Many of these young adults initiated dialysis as children or teenagers. Risk factors associated with the development of CAC are also seen in the pediatric dialysis population. To date, reports of cardiac calcifications in pediatric patients receiving maintenance dialysis are limited to post-mortem studies. We present two pediatric patients with ANCA-positive vasculitis diagnosed with cardiac calcifications while receiving maintenance dialysis. Hyperphosphatemia and an elevated CaxP product were seen in both patients and probably contributed to the development of extraskeletal calcifications. In addition, both patients had an underlying systemic inflammatory disease and significant weight loss/malnutrition that may have contributed to the early and rapid onset of cardiac calcifications.

Entities:  

Mesh:

Year:  2003        PMID: 12774220     DOI: 10.1007/s00467-003-1156-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

Review 1.  Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.

Authors:  P Stenvinkel
Journal:  Blood Purif       Date:  2001       Impact factor: 2.614

Review 2.  Wegener's granulomatosis: unusual presentations.

Authors:  R A Watts
Journal:  Hosp Med       Date:  2000-04

3.  Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients.

Authors:  P Raggi
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

4.  Aortic valve disease in patients with Wegener's granulomatosis.

Authors:  A Davenport; J Goodfellow; S Goel; A G Maciver; P Walker
Journal:  Am J Kidney Dis       Date:  1994-08       Impact factor: 8.860

5.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Authors:  Santhi K Ganesh; Austin G Stack; Nathan W Levin; Tempie Hulbert-Shearon; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

Review 6.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Authors:  G A Block; F K Port
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

7.  Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.

Authors:  Angela Yee Moon Wang; Jean Woo; Mei Wang; Mandy Man Mei Sea; Ricky Ip; Philip Kam Tao Li; Siu Fai Lui; John Elsby Sanderson
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

8.  Periaortitis heralding Wegener's granulomatosis.

Authors:  Roux-Serratrice Christine de; Jacques Serratrice; Brigitte Granel; Patrick Disdier; Jean-Michel Bartoli; Xavier Pache; Philippe Astoul; Lucienne Garbe; Alain Branchereau; Pierre-Jean Weiller
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

9.  Cardiovascular disease in pediatric chronic dialysis patients.

Authors:  Blanche M Chavers; Shuling Li; Allan J Collins; Charles A Herzog
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

10.  Cardiovascular mortality in children and young adults with end-stage kidney disease.

Authors:  R S Parekh; C E Carroll; R A Wolfe; F K Port
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

View more
  7 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 2.  Watching bone cells at work: what we can see from bone biopsies.

Authors:  Frank Rauch
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

3.  Intima media thickness in children undergoing dialysis.

Authors:  Luis Antonio Chavarria; Alejandra Aguilar-Kitsu; Patricia Rosas; Arturo Fajardo; Leticia Mendoza-Guevara; Lorena Sanchez; Claudia Zepeda; Pilar Ibarra; Alejandro Luna; Bengt Lindholm; Elvia García-López
Journal:  Pediatr Nephrol       Date:  2012-05-03       Impact factor: 3.714

Review 4.  Chronic kidney disease and inflammation in pediatric patients: from bench to playground.

Authors:  Roberto Pecoits-Filho; Lucimary C Sylvestre; Peter Stenvinkel
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

5.  Reliable individualized monitoring improves cholesterol control in kidney transplant recipients.

Authors:  David K Hooper; Cassie L Kirby; Peter A Margolis; Jens Goebel
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

6.  Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study.

Authors:  Abeer Yasin; Daisy Liu; Luan Chau; Joaquín Madrenas; Guido Filler
Journal:  BMC Nephrol       Date:  2013-02-17       Impact factor: 2.388

7.  Vascular calcification in an adolescent treated with long-term peritoneal dialysis.

Authors:  Mesiha Ekim; Suat Fitoz; Z Birsin Ozcakar; Fatos Yalcinkaya
Journal:  Int J Nephrol       Date:  2011-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.